Status:

COMPLETED

Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects

Lead Sponsor:

Karabuk University

Conditions:

Neural Tube Defects

Folic Acid

Eligibility:

FEMALE

18-45 years

Brief Summary

Aim of this study is to investigate and statistically reveal the prevalence and awareness of folic acid usage in pregnant women who have at least one of the risk factors for neural tube defects, to ex...

Eligibility Criteria

Inclusion

  • over 18 years
  • Under 45 years of age
  • Having at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth defect with aneuploidy, history of GDM or known DM) for Case Group.
  • Singleton pregnant women

Exclusion

  • under 18 years old
  • Above 45 years old
  • Multiple pregnancies

Key Trial Info

Start Date :

February 20 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 20 2023

Estimated Enrollment :

267 Patients enrolled

Trial Details

Trial ID

NCT06135883

Start Date

February 20 2023

End Date

August 20 2023

Last Update

November 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prof. Dr. Cemil Tascioglu City Hospital

Istanbul, Sisli, Turkey (Türkiye), 34384